COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program During the Omicron Surge.
Transplantation
; 2022 Oct 13.
Article
in English
| MEDLINE | ID: covidwho-2229011
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Topics:
Variants
Language:
English
Year:
2022
Document Type:
Article
Affiliation country:
TP.0000000000004418
Similar
MEDLINE
...
LILACS
LIS